Calendar

«« Nov 2007 »»
S M T W T F S
       
1
2
3
4
5
6
7
8
9
10
11
12
13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30

Search Box


HealthCentral Top Site Award

IBS Tales Hope Award

Ai in the media

Reuters Health:
Brain's endocannabinoid system a potential target for new antidepressants

KETV-7, Omaha:

WLWT5, Cincinnati:

LinkBlog

Cannabis, the mind and society: the hash realities (PDF - free reg. req'd)

The Role of Cognitive and Behavioral Therapies in the Treatment of Insomnia

Have you outsourced your brain?

  More

Contact

Mailing List

RSS Feeds








Translation

Disclaimer

All content within Anxiety Insights is provided for general information only, and should not be treated as a substitute for the medical advice of your doctor or other health care professional.

Anxiety Insights is not responsible or liable for any diagnosis made by a reader based on the content of this website.

Anxiety Insights is not liable for the contents of any external internet sites listed, nor does it endorse any commercial product or service mentioned or advised on any of the sites.

Always consult your doctor if you are in any way concerned about your health.

recommended links

Depression is Real's Down & Up Show
      Weekly audio-casts from the
      Depression Is Real Coalition

we support

Kiva.org - micro loans that change lives

Moving a Nation to Care : Post Traumatic Stress Disorder and America's Returning Troops, by Ilona Meagher

No Longer Lonely.com

"just don't smoke"


"Don't smoke, whatever you do, just don't smoke."
                        Yul Brynner

Hit Counter

Total: 998,202
since: 14 May 2006

Admin console

Log-In

My Blog    My Profile

Leave Message

Add as neighbors






Blogion.com

Blog Flux Directory



Blogarama - The Blogs Directory

blog search directory

BlogTagstic - Blog Directory

Find Blogs in the Blog Directory



LS Blogs

Top Health Sites





Health Blogs - Blog Top Sites

Bloggapedia - Find It!

Latest tagged entries for 'BENZODIAZEPINES'


next »

Warning issued against taking St Johns Wort with epilepsy drugs

Tuesday, 6 November 2007 8:59 A GMT+01
The British Medicines and Healthcare products Regulatory Agency has issued a reminder to healthcare professionals that any antiepileptic medicine may interact with St John's wort, and that their concomitant use is therefore not recommended.

Abstract: Long-term, high-dose benzodiazepine prescriptions in veteran patients with PTSD: Influence of preexisting alcoholism and drug-abuse diagnoses

Tuesday, 30 October 2007 8:28 A GMT+01
Databases from the New England Veterans Integrated Service Network were analyzed to determine factors associated with long-term, high-dose anxiolytic benzodiazepine prescriptions dispensed to patients with PTSD & existing alcoholism and/or drug abuse

Abstract: Comparisons of psychopharmacological and psychological treatments for anxiety disorders

Wednesday, 26 September 2007 9:55 A GMT+01
A number of meta-analyses have led to contradictory results regarding the efficacy of the psychological and pharmacological treatment of anxiety disorders.

Abstract: Benzodiazepines in generalized anxiety disorder

Monday, 24 September 2007 9:31 A GMT+01
The objective of this study was to assess the effectiveness and efficacy of benzodiazepines in the treatment of GAD based on trial drop-out rates.

Clinical updates in sleep medicine: Benzodiazepines

Tuesday, 28 August 2007 9:13 A GMT+01
Despite the well-documented efficacy and safety records of benzodiazepines, physicians elect to use agents from a number of pharmaceutical classes to treat insomnia, despite absent safety and efficacy data to support their use.

More DUI stops find Xanax

Tuesday, 14 August 2007 9:45 A GMT+01
Hillsborough sheriff's Deputy Larry Morrell pulled over the 26-year-old woman after she crashed into an apartment gate on Brandon's Regency Avenue.

[Xanax treated] Abilene Zoo elephant dies at age 49

Tuesday, 14 August 2007 9:34 A GMT+01
ABILENE, Texas (AP) - A stressed-out elephant that had been treated with Xanax died Monday morning at age 49, zoo officials said.

For anxiety, look beyond status quo drugs: Augmentation most commonly involves atypicals; benzodiazepines or buspirone; and anticonvulsants.

Wednesday, 25 July 2007 9:25 A GMT+01
Selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors are first-line pharmacotherapy for most patients with generalized anxiety disorder and social anxiety disorder, but a substantial number of patients need more.

FDA safety label changes for lorazepam (Ativan®) and fluoxetine (Sarafem®)

Wednesday, 18 July 2007 8:59 A GMT+01
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research (CDER) has approved safety label changes for lorazepam (Ativan®) and fluoxetine (Sarafem®).

Abstract: Reduced γ-Aminobutyric Acid a–Benzodiazepine binding sites in insular cortex of individuals with panic disorder

Tuesday, 3 July 2007 9:42 A GMT+01
Benzodiazepine drugs are highly effective anxiolytic medications, but the role of the benzodiazepine-γ-aminobutyric acid A-chloride ion channel macromolecular complex in the pathophysiologic mechanism of anxiety is not well understood.

Abstract+: Managing side effects of anxiolytics

Monday, 2 July 2007 9:02 A GMT+01
This article discusses the common side effects of benzodiazepines and other anxiolytic agents in the treatment of anxiety disorders.

NIHM study to examine effects of excluding benzodiazepines in Medicare Part D coverage

Saturday, 23 June 2007 11:27 P GMT+01
A new research grant funded by the National Institute of Mental Health will examine the costs and benefits of excluding a commonly prescribed class of anti-anxiety medications - benzodiazepines - from coverage in the new Medicare Part D program

Abstract: Antidepressants but not benzodiazepines hinder CBT response in Panic Disorder

Wednesday, 6 June 2007 8:48 A GMT+01
This study examined naturalistic medication use and cognitive behavioral therapy (CBT) treatment outcomes in 105 patients meeting DSM-IV criteria for panic disorder (PD), assessed by structured clinical interview.

Abstract+: Combination of psychotherapy and benzodiazepines versus either therapy alone for Panic Disorder

Tuesday, 15 May 2007 9:50 A GMT+01
The efficacy of combined psychotherapy and benzodiazepine treatment for panic disorder is still unclear despite its widespread use. The present systematic review aims to examine its efficacy compared with either monotherapy alone.

Patients with anxiety benefit from early addition of Alprazolam to therapy

Tuesday, 3 April 2007 9:29 A GMT+01
Insomnia and overall wellbeing in patients with generalized anxiety disorder (GAD) improve more quickly with early treatment combining alprozalam [Xanax] in combination with a SSRI or SNRI antidepressant

[USA] Spending on psychotropic drugs surges

Saturday, 31 March 2007 6:59 A GMT+01
Spending on prescription drugs to treat depression, anxiety, pain, schizophrenia and other conditions climbed from $7.9 billion in 1997 to $20 billion in 2004 - over a 150 percent increase,

UN report warns of risks with some internet pharmacies

Friday, 9 March 2007 4:36 A GMT+01
The United Nation's International Narcotics Control Board (INCB) warns that unregulated internet pharmacies are posing a high risk to patients.

Less-severe side effects reported when CBT added to medication

Saturday, 3 March 2007 8:02 A GMT+01
Medication side effects may not only be an annoyance for patients but an obstacle to successful treatment. A dose of psychotherapy may make it easier for people with panic disorder to tolerate these side effects.

FDA approves Teva Pharma's generic Alprazolam ER tablets

Friday, 2 March 2007 8:00 A GMT+01
Teva Pharmaceutical Industries Ltd. has announced that the U.S. Food and Drug Administration has granted approval for the company's generic Alprazolam Extended Release 0.5 mg, 1 mg, 2 mg and 3 mg tablets.

FDA alert on fake Internet purchased Ambien®, Ativan®, Lexapro® and Xanax®

Saturday, 17 February 2007 5:13 A GMT+01
The FDA has become aware that a number of Americans who placed orders for specific drug products over the Internet (Ambien, Xanax, Lexapro, and Ativan), instead received a product that, according to preliminary analysis, contains haloperidol

[USA] Actavis launches Alprazolam ER tablets

Friday, 16 February 2007 8:44 A GMT+01
The Icelandic pharmaceutical company, Actavis, has announced that it has been granted U.S. Food & Drug Administration approval to market Alprazolam ER tablets.

Alexza updates status of its Panic Disorder candidate drug AZ-002

Tuesday, 13 February 2007 6:22 A GMT+01
Alexza Pharmaceuticals is developing inhalable drugs for anxiety, pain and schizophrenia agitation which give results within seconds instead of minutes.

Abstract+: Combined pharmacotherapy and CBT for anxiety disorders

Sunday, 4 February 2007 8:08 A GMT+01
Both pharmacotherapy and cognitive-behavioural therapy are effective treatments for anxiety disorders. The present editorial reviews the current status of combination treatments

Benzodiazepines got bum rap on hip fractures

Friday, 19 January 2007 7:40 A GMT+01
Benzodiazepine use was not shown to be associated with hip fractures after all, according to a new study from the Department of Ambulatory Care and Prevention (of Harvard Medical School and Harvard Pilgrim Health Care).

Abstract: Cognitive, psychomotor and actual driving performance of 1mg Alprazolam (Xanax®)

Friday, 19 January 2007 7:32 A GMT+01
The present study was designed to compare the effects of alprazolam XR (1 mg) and alprazolam IR (1 mg) on actual driving ability and cognitive function.

next »